Zdrowie i gospodarka · 17/04/2019

FDA Hosts Public Workshop to Advance Analysis Data Standards in Drug Development and Regulatory Review

The FDA is convening a public workshop to discuss challenges and opportunities in developing and implementing analysis data standards in drug development and regulatory review, as part of its commitment to advance these standards under the Prescription Drug User Fee Reauthorization Performance Goals and Procedures